Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.

Biotechnology

Health & Wellness

Reneo Pharmaceuticals

Reneo Pharmaceuticals' headquarters in San Diego, CA, United States

Ashley F. Hall

Ricardo Graham

Alejandro Dorenbaum

Maggie Loeffler, CPA

Lynn Purkins

Bali Muralidhar

Scott Weiner

Eric Dube

Arthur Pappas

Niall O’Donnell

Stacey D. Seltzer

Roshawn Blunt

Ed Mathers

The Senior Management team at Reneo Pharmaceuticals is responsible for setting the strategic direction and overseeing the execution of the company's initiatives focused on developing therapies for genetic mitochondrial diseases. This team, comprised of directors and top executives, collaborates to ensure effective operational management, financial oversight, and regulatory compliance, while fostering innovation and driving the company's clinical programs forward. Their collective leadership guides Reneo in achieving its mission to improve patient outcomes through groundbreaking therapies.

Senior Management

The Leadership Team at Reneo Pharmaceuticals is responsible for guiding the company’s strategic vision and operational execution in the development of therapies for genetic mitochondrial diseases. Comprising key executives including the Chief Medical Officer, Chief Development Officer, President & CEO, and Chief Business Officer, the team collaborates to advance clinical programs, secure funding, and foster partnerships that enhance Reneo's growth and innovation in the pharmaceutical sector.

Leadership Team

The Accounting Team at Reneo Pharmaceuticals is responsible for maintaining accurate financial records, ensuring compliance with accounting standards, and providing financial reporting to facilitate decision-making. They manage the accounting processes related to clinical trials and pharmaceutical development, ensuring that financial resources are allocated efficiently to support the company's mission in advancing therapies for genetic mitochondrial diseases.

Accounting Team

The Clinical Operations team at Reneo Pharmaceuticals is responsible for overseeing the design, execution, and management of clinical trials aimed at evaluating new therapies for genetic mitochondrial diseases. The team ensures compliance with regulatory standards, coordinates with cross-functional partners, and monitors trial progress to ensure safe and effective treatments are delivered to patients. By leveraging expertise in clinical affairs and toxicology, they strive to advance Reneo's innovative solutions from development to successful regulatory approval.

Clinical Operations

The Regulatory Affairs and Compliance team at Reneo Pharmaceuticals is responsible for ensuring that all clinical development activities adhere to regulatory standards and guidelines. This team works closely with global regulatory agencies to secure approvals for new therapies, manages compliance with regulations throughout the drug development lifecycle, and facilitates communication between the company and regulatory bodies to support the advancement of treatments for genetic mitochondrial diseases.

Reneo Pharmaceuticals

Org chart

Board & advisors

Teams

Senior Management

Leadership Team

Accounting Team

Clinical Operations

Regulatory Affairs and Compliance

Offices

Reneo Pharmaceuticals

Org chart

Board & advisors

Teams

Senior Management

Leadership Team

Accounting Team

Clinical Operations

Regulatory Affairs and Compliance

Offices

Related companies